Beryllium in Aerospace Industry: Applications, Exposure Hazards, and Safety Controls
Abstract: Beryllium in Aerospace
Beryllium, a light and durable metal found in numerous industries, is not just known by its physical characteristics but also for its related potential health risks. Its high gravimetric and volumetric energy density make beryllium a very attractive material in next-generation propulsion systems, such as rockets and missiles. This could lead to a real step forward in fuel efficiency and payload capacity. However, its general toxicity and the necessary control and prevention measures, such as high combustion temperatures and toxic oxide emissions, have limited its practical applications. It also has high structural strength with an excellent stiffness-to-weight ratio, high thermal conductivity, and dimensional stability under extremely varied temperature conditions. Consequently, the role of Beryllium in aerospace is evident in a variety of parts, ranging from optical systems and guidance structures to thermal management assemblies and electronic connectors. In spite of the documentation and historical surveys which associate beryllium with guidance and structural components in Cold War–era U.S. missiles and launch vehicles—for example, early Atlas and Titan programs and their guidance hardware—it presents significant challenges due to the exposure of its toxic byproducts.
In addition to this, recent research on the biological interactions of beryllium has provided important insights into how it affects the immune system of living organisms. When beryllium enters the body, it often forms beryllium ions (Be²⁺), which can trigger strong immune reactions. Because these ions can mimic other metal ions like magnesium, they can interfere with normal biological processes and confuse the immune system, leading to inflammation. Beryllium can bind to certain proteins in the body, activating T-cells and causing immune responses that may result in beryllium-related diseases such as chronic beryllium disease (CBD). Exposure to beryllium increases the risk of serious diseases such as dermatitis (skin rashes and ulcers), pneumonia (inflammation of the lungs), granulomatosis (nodules in body tissues), cancer, and it also interferes with the function of important organs such as the liver, kidneys, heart, brain, and spleen. Beryllium has the potential to damage DNA and cause genetic mutations, disorders in reproduction, and developmental defects. It may further cause testicular damage and reduced male fertility and fetal injury in pregnant women, which then results in abnormal growth and birth defects. Serious health ailments arise when beryllium dust or fumes are inhaled, exemplified by symptoms similar to asthma or heart disease; sometimes, it may cause lung cancer. Strict safety regulations and exposure limits will help in maintaining workers’ safety and reduce the adverse health risks associated with handling beryllium.
Beryllium in aerospace: Introduction

Metal particles are a major choice for fuel and propellant used in rocket and missile propulsion. These fuels are beryllium, boron, aluminum, magnesium, titanium, etc. The presence of metal particles in rocket fuel and propellants augments the propulsive performance which has been validated for several decades (since the 1950s) in terms of energy release, specific impulse, and density-specific impulse [1-5]. Among all, beryllium is a potential metal that produces maximum energy on combustion both on gravimetric (67 KJ/g) and volumetric (126 KJ/cm3) levels [6]. However, beryllium and its oxide (BeO) are counted as great toxic materials for humans and animals. Therefore, even though beryllium has a very high energy level, its application is not in practice due to health issues in workers or researchers conducting experimental evaluations. Numerous tests have been conducted to understand beryllium-based fuel and propellants for implementation in real-time rockets and missiles. It is expected that if one can address the problems associated with the primary test and evaluations, beryllium could fill the gap in the high-energy materials used in rocket propulsion.
So far, there has been no available literature prescribing any system that gives a safe screening method for beryllium-based solid fuels and propellants in rocket propulsion applications. The significance of the present invention can be justified by elaborating on the importance of beryllium in combustion fields and the issues associated with people working in beryllium environments. Therefore, beryllium has two sides of a coin:
- the high energy level of beryllium on combustion
- beryllium’s toxic effects.
These issues are covered in more detail below to help in understanding the technicalities of beryllium and also why it is essential to employ a safe screening mechanism when investigating beryllium.
TECHNICAL DETAILS OF BERYLLIUM IGNITION/COMBUSTION

The fundamental issue with beryllium ignition and combustion is twofold: the first is the igniting of beryllium particles at high temperatures, and the second is the high toxicity of both beryllium and its combustion products. Due to its high toxicity, beryllium is recommended strictly for applications in deep space propulsion. The beryllium ignition is analogous to aluminum since both ignite on melting. The beryllium particles always exist with beryllium oxide, and the melting point of beryllium is less than its oxide. Therefore, when the temperature rises the core beryllium first melts (at 1556 K) and then ignites [7-8]. Beryllium typically ignites at temperatures around 2600 K under atmospheric pressure, which is a little below the metal’s boiling point of 2757 K, although very fine particles in a dense oxidizer can ignite at temperatures as low as 1300 K [7-9]. The greater the concentration of beryllium particles, the lower their ignition temperature due to the collective effect [9]. Previous literature suggested a safe experimental evaluation of beryllium using sealed capsules, followed by careful disposal of the combustion products. [8]. It was decades ago (around 1973) when the United States government did not allow the testing of a beryllium-based rocket motor in public areas, and finally, it was tested on a Pacific Island to prevent hazardous exposure to humans [10].
HEALTH HAZARDS ASSOCIATED WITH EXPOSURE TO BERYLLIUM
Beryllium has been recognized as a toxic agent since 1930 and can cause various major diseases in humans and animals when exposed or inhaled [11]. It was first recognized in Germany in 1933 and later in Soviet Union in 1936 [10]. It became prominent among workers associated with the fluorescent-lamp industries in the late 1940s [10]. The disease of beryllium exposure includes dermatitis, pneumonia, granulomatosis, cancer, and a major lung disease called chronic beryllium disease (CBD) or berylliosis [12-15]. The beryllium occupational exposure limit was fixed at 2.0 µg/m3 in 8 hrs. In most countries, like the USA, Korea, etc., it was noticed that CBD was developed even below this limit [13, 16]. The beryllium handling related diseases not only developed in workers associated with the industries, but also it was noticed that it developed in family members too, whoever came in contact with those workers or their clothes [17-20].
In the United States, CBD was first reported in 1943, and it was spread mostly in infants, elderly people, and those who already had other major health issues [16, 21]. CBD is basically a granulomatous lung disease; hence, it impacts badly on the respiratory system badly and finally promotes lung cancer. Therefore, aerosol characteristics of beryllium, such as particle size, morphology, and surface chemistry, play an important role. In an investigation, it was reported that particles below 10 µm may contribute lower risk of CBD [16]. Generally, fine beryllium particles may remain suspended in the air for around 10 days [22]. However, workers associated with beryllium mining operations (beryllium ores) have been observed free from CBD [16]. CBD severely targets major body organs such as the lungs, liver, kidneys, skeleton, testicles (reduce sperm count), heart, spleen, brain, RBC counts, bone marrow, lymph nodes, DNA, skin (ulcer with lumps), and overall human immune systems [13, 23].
Beryllium and its compounds may enter the body through beryllium-exposed food and drinking water (fish from contaminated water due to electronic waste), inhalation, and skin [12, 16, 24]. A few animals, such as monkeys, rabbits, dogs, and rats, were exposed to beryllium or its compounds to study the toxic effects and the same to replicate them in humans. Pulmonary tumors were found in monkeys due to exposure to beryllium sulfate and beryllium oxide [10]. Beagle dogs were exposed to beryllium-based rocket exhaust, and the dogs were killed within 30-36 months due to pulmonary granulomas [10, 25]. Osteosarcoma (a type of bone cancer) has been reported in rabbits on beryllium and its compounds [23]. When pregnant rats were exposed to beryllium nitrate, it spoiled the fetuses in most of the rats, and the surviving rat pups died within 2-3 days of the delivery [26].
HEALTH IMPLICATIONS
The course of beryllium illnesses is heterogeneous and depends on several factors such as the extent and duration of exposure, personal genetic predisposition, and underlying disease. Over time, chronic lung inflammation and fibrosis occur in CBD patients with progressive impairment of lung function. Among various beryllium exposures, the intoxication of liver-related disease (uric acid and creatinine enhancements) has been treated by an Indian medicine called Liv-52 by Himalaya [27]. The medicine has given a positive result, especially on rats and dogs suffering from beryllium-exposed diseases.
Early diagnosis and removal from beryllium exposure are important for improving outcomes. Routine monitoring of lung function by pulmonary function tests is recommended for those with a history of exposure, as the disease may be asymptomatic until extensive damage has occurred. New advances in medical research continue to provide insight into the mechanisms behind beryllium-induced diseases and offer the possibility for therapeutic approaches toward the modulation of the immune response to prevent disease progression.
Recent development of insights into the biomolecular mechanisms of CBD opens perspectives for new therapeutic approaches.
Conclusion: Beryllium in aerospace

Based on the literature given above, it is clear that beryllium is one of the most promising advanced materials for current aerospace and propulsion applications. The exceptional high energy density per unit mass and volume makes beryllium a highly suitable candidate for rocket applications. So, systems based on beryllium are able to improve their specific impulse, produce more thrust, and carry more substantial payload capacity, ultimately making it a meaningful step towards the development of next-generation aerospace technology. Apart from propulsion, beryllium also has much value because of its high thermal conductivity and extremely good dimensional stability, which produces stronger and more resilient structural parts. But these benefits are neutralized by significant health risks. Long-term exposure to beryllium dust or fumes can causes serious medical conditions which include CBD, acute pneumonia, skin rashes and ulcers, high risk of cancer, genetic disorders, reproductive damage such as testicles injury, and abnormalities in the development of fetuses.
By using proper protective equipment, health surveillance of the workers on a continuous basis and maintaining a sealed environment, the risks can be minimized. For future development, some safe processing methods and establishment of a standardized testing method are required for beryllium-based fuels. Strict public policies, environmental management, proper education and some rigorous safety techniques will be very useful in minimizing these risks.
Lastly, beryllium-based fuels for propulsion should be limited to upper-stage missile applications and deep-space missions because of the risks which are involved in atmospheric contamination.
Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Further, at ENTECH Online, you’ll find a wealth of information.
References:
- Price, E. W. (1983). Combustion of metallized propellants, fundamentals of solid propellant combustion. Edit. KK. Kuo, M. Summerfield, Progress in Astronautics and Aeronautics, AIAA90.
- Price, E. W., & Sigman, R. K. (2000). Combustion of aluminized solid propellants. Solid propellant chemistry, combustion, and motor interior ballistics, 185, 663–687.
- Devenas A. (Ed.). (1993). Solid rocket propulsion technology. Pergamon Press, New York.
- Kubota, N., Miyata, K., Kuwahara, T., Mitsuno, M., & Nakagawa, I. 1991a. Combustion of energetic fuel for ducted rockets (I). Propellants Explosives Pyrotechnics, 16(2), 51–54.
- Liu, D., Xia, Z., Huang, L., & Hu, J. (2014a). Boron Particle Combustion in Solid Rocket Ramjets. Journal of Aerospace Engineering, 28(4), 04014112.
- Risha, G. A., Evans, B. J., Boyer, E. & Kuo, K. K. (2007). Metals, energetic additives, and special binders used in solid fuels for hybrid rockets. Progress in Astronautics and Aeronautics, 218, 413–456.
- Maček, A. (1967, January). Fundamentals of combustion of single aluminum and beryllium particles. In Symposium (International) on Combustion (Vol. 11, No. 1, pp. 203-217). Elsevier.
- Macek, A., Friedman, R., & Semple, J. M. (1963). Technique for the study of Combustion of Beryllium Particles. In AAIA Heterogeneous Combustion Conference, CONF-391-2, American Institute of Aeronautics and Astronautic.
- Davydov, D. A., Kholopova, O. V., & Kolbasov, B. N. (2007). Some characteristics of fine beryllium particle combustion. Journal of nuclear materials, 367, 1079-1084.
- Robinson, F. R. (1973). Toxicity of beryllium and other elements in missile propellants. Clinical Toxicology, 6(3), 497-502.
- Jameson, C. W. (1996). Introduction to the conference on beryllium-related diseases. Environmental Health Perspectives, 104(suppl 5), 935-936.
- Kim, K. W., Kim, D., Won, Y. L., & Kang, S. K. (2013). Effects of beryllium on human serum immunoglobulin and lymphocyte subpopulation. Toxicological Research, 29(2), 115-120.
- Drobyshev, E., Kybarskaya, L., Dagaev, S., & Solovyev, N. (2019). New insight in beryllium toxicity excluding exposure to beryllium-containing dust: accumulation patterns, target organs, and elimination. Archives of toxicology, 93(4), 859-869.
- Epstein PE, Dauber JH, Rossman MD, Daniele RP. 1982. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med 97:213–216.
- Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 320:1103–1109.
- Kolanz, M. E. (2001). Introduction to beryllium: uses, regulatory history, and disease. Applied occupational and environmental hygiene, 16(5), 559-567.
- Eisenbud, M., & Lisson, J. (1983). Epidemiological aspects of beryllium induced nonmalignant lung disease: A 30-year update. Journal of occupational medicine, 196-202.
- Eisenbud, M., Wanta, R. C., Dustan, C., Steadman, L. T., Harris, W. B., & Wolf, B. S. (1949). Non-occupational berylliosis. Journal of industrial hygiene and toxicology, 31(5), 282-94.
- Lieben, J., & Metzner, F. (1959). Epidemiological findings associated with beryllium extraction. American Industrial Hygiene Association Journal, 20(6), 494-499.
- Newman, L. S., & Kreiss, K. (1992). Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis, 145(5), 1212-4.
- Van Orostrand, H. S., Hughes, R., & Carmody, M. G. (1943). Chemical Pneumonia in Workers extracting Beryllium Oxide. Cleveland Clinic Quarterly, 10(1), 10-18.
- Agency for Toxic Substances and Disease Registry. Public health statement. Beryllium. Cas#: 7440-41-7. Buford Highway, Atlanta, Georgia, USA; 2008. a. p. 1-7.
- Cooper, R., & Harrison, A. (2009). The uses and adverse effects of beryllium on health. Indian Journal of Occupational and Environmental Medicine, 13(2), 65. https://doi.org/10.4103/0019-5278.55122
- Tinkle, S. S., Antonini, J. M., Rich, B. A., Roberts, J. R., Salmen, R., DePree, K., & Adkins, E. J. (2003). Skin as a route of exposure and sensitization in chronic beryllium disease. Environmental Health Perspectives, 111(9), 1202–1208. https://doi.org/10.1289/ehp.5999
- Finch, G. L., Mewhinney, J. A., Hoover, M. D., Eidson, A. F., Haley, P. J., & Bice, D. E. (1990). Clearance, translocation, and excretion of beryllium following acute inhalation of beryllium oxide by beagle dogs. Fundamental and applied toxicology, 15(2), 231-241.
- Mathur, R., Sharma, S., Mathur, S., & Prakash, A. O. (1987). Effect of beryllium nitrate on early and late pregnancy in rats. Bull. Environ. Contam. Toxicol.; (United States), 38(1).
- Mathur, S. (1994). Role of Liv-52 in protection against beryllium intoxication. Biological trace element research, 41(3), 201-215.




